Product pipeline

Serodus has an extensive pipeline within diabetes and diabetic comorbidities.

SER150DN

SER150 is a small molecule with anti-inflammatory properties.

SER130AMI

SER130 is a potent interleukin-4 (IL-4) agonist.

SER140T2D

SER140 is a potent interleukin-1 (IL-1) receptor antagonist.

SER190DFU

SER190 is an IL-1β receptor antagonist

SER100PH

Pulmonary Hypertension is a chronic, progressive disease characterized by elevated blood pressure in the pulmonary arteries. This elevated pressure ultimately results in right ventricular failure and death.

Product

Preclinical phase

Phase i

Phase ii a

Phase ii b

Phase iii

Approved

SER150DN

Diabetic nephropathy

SER130AMI

Acute Myocardial Infarction

SER140T2D

Type 2 Diabetes

SER190DFU

Diabetic Foot Ulcers

SER100PH

Pulmonary Hypertension